ZO

Zomedica Corp.

  • CIK: 0001684144
  • EIN: 00-0000000
  • Business address: 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR, Michigan, 48108

Information

  • Mailing address
    100 PHOENIX DRIVE, SUITE 125, ANN ARBOR, MI, 48108
  • Phone
    (734) 369-2555
  • State location
    Michigan
  • State of incorporation
    N/A
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About Zomedica Corp.

Zomedica Corp. (CIK: 0001684144) is an American company incorporated in the state of Michigan. Head office is located at 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR, Michigan, 48108. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Zomedica Corp. is a public company and trade via Over-The-Counter (OTC).

Old names:

  • Zomedica Pharmaceuticals Corp. from 2016-08-Sep to 2020-28-Sep

Ownership

Owner Filings Transaction Date Type of Owner
Donato Peter 0001408320 Mar-16-2023 officer: Chief Financial Officer
Nichols Pamela 0001944747 Aug-23-2022 director
Blair Anthony K 0001297970 Jun-13-2022 officer: Chief Operating Officer
DeHaan-Fullerton Karen 0001934689 Jun-13-2022 officer: Chief Counsel and Secretary
HEATON LARRY C II 0001213207 Oct-01-2021 officer: President
Lock Adrian 0001892827 Oct-01-2021 officer: VP and General Manager
Whelan Sean 0001418307 Sep-13-2021 director
Cotter Ann 0001821115 Oct-01-2020 officer: Chief Financial Officer & Sec.
Wolfenberg Christopher 0001821087 Aug-06-2020 director
MACLEOD CHRISTOPHER ROSS 0001765476 Jul-09-2020 director
Cohen Robert 0001815574 Jun-16-2020 officer: Interim CEO
POWERS JOHNNY D 0001134545 Aug-16-2019 director
Herbst Bruk 0001721753 Mar-29-2018 officer: Chief Commercial Officer
Morley Stephanie 0001721793 Mar-29-2018 officer: COO & VP of Product Dev
Rowe Jeffrey M 0001619009 Mar-23-2018 director
Williams Rodney James 0001722780 Mar-23-2018 director
LeBar James 0001721721 Jan-24-2018 director
Shameze Rampertab 0001721810 Jan-08-2018 director, officer: Chief Financial Officer
Solensky Gerald JR 0001721759 Dec-19-2017 director, 10 percent owner, officer: President and CEO
Eagleson Jane 0001721712 Nov-20-2017 director
DiMarzo Robert 0001721715 Nov-20-2017 officer: EVP of Global Strategy
Robitaille Thomas 0001721717 Nov-20-2017 director
Rowe Family GST Trust 0001722146 Nov-20-2017 10 percent owner

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zomedica Corp.

Filings Format Description Filed/Effective File/Film Number
8-A12G Document

Form for registration of a class of securities pursuant to section 12(g)

Acc-no: 0001654954-25-009862 (34 Act) Size: KB		 Aug-20-2025

000-56775

251236944
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-009503 ( Act) Size: 0 KB		 Aug-13-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-009402 ( Act) Size: 0 KB		 Aug-12-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-009400 ( Act) Size: 0 KB		 Aug-12-2025

8-K Document

Current report filing

Acc-no: 0001654954-25-009136 (34 Act) Size: KB		 Aug-06-2025

001-38298

251190471
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001558370-25-010512 (34 Act) Size: KB		 Aug-06-2025

001-38298

251189422
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-007027 ( Act) Size: 0 KB		 Jun-16-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-007017 ( Act) Size: 0 KB		 Jun-16-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-007015 ( Act) Size: 0 KB		 Jun-16-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-007004 ( Act) Size: 0 KB		 Jun-16-2025

8-K Document

Current report filing

Acc-no: 0001654954-25-006839 (34 Act) Size: KB		 Jun-11-2025

001-38298

251040157
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001654954-25-006676 (34 Act) Size: KB		 Jun-06-2025

001-38298

251029944
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001654954-25-006323 (34 Act) Size: KB		 May-30-2025

001-38298

251009568
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001654954-25-006258 (34 Act) Size: KB		 May-30-2025

001-38298

251005222
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-006001 ( Act) Size: 0 KB		 May-21-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-005944 ( Act) Size: 0 KB		 May-20-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0001654954-25-005943 ( Act) Size: 0 KB		 May-20-2025

8-K Document

Current report filing

Acc-no: 0001654954-25-005749 (34 Act) Size: KB		 May-15-2025

001-38298

25953153
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0001558370-25-007874 (34 Act) Size: KB		 May-15-2025

001-38298

25952724
DEFA14A Document

Additional definitive proxy solicitation materials

Acc-no: 0001654954-25-005527 (34 Act) Size: KB		 May-13-2025

001-38298

25940628

Recent 20 filings. View all Zomedica Corp. filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • Zomedica Corp. overview
  • Zomedica Corp. job
  • Zomedica Corp. stock
  • Zomedica Corp. ownership
  • Zomedica Corp. CEO
  • Zomedica Corp. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

atai Life Sciences Luxembourg S.A.
Update: Sep 23, 2025
Hyperliquid Strategies Inc
Update: Sep 05, 2025
Polaryx Therapeutics, Inc.
Update: Sep 05, 2025
Nasus Pharma Ltd
Update: Jul 10, 2025
Promicell, Inc.
Update: May 30, 2025
Maius Pharmaceutical Group Co., Ltd.
Update: Mar 01, 2025

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 1952 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 2993 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 2049 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 3717 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1677 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1122 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 2792 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 4765 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4793 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by